Suneel Gupta

This inventor holds 30 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Impax Laboratories, Inc., Amneal Pharmaceuticals LLC. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suneel Gupta. Retrieved from https://idiyas.com/inventor/suneel-gupta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 9)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 3.5

ph-index = 8

Forward Citations = 205(Granted Patents)

Company Filing History:

17 out of 29

Impax Laboratories, Inc.

patents

13 out of 31

Amneal Pharmaceuticals LLC

patents

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

Levodopa

Controlled Release

Muco-Adhesive

Formulation

Dosing Regimen

Pharmaceutical

Drug Delivery

Therapeutics

Bioavailability

Esters

Medication

Chronic Conditions

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12691074 - Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof (2026-07-28),

2. 12491164 - Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof (2025-12-09),

3. 12458616 - Levodopa dosing regimen (2025-11-04),

4. 12453710 - Levodopa dosing regimen (2025-10-28),

5. 12447139 - Levodopa dosing regimen (2025-10-21),

6. 12403099 - Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof (2025-09-02),

7. 12370163 - Levodopa dosing regimen (2025-07-29),

8. 12303605 - Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof (2025-05-20),

9. 12303482 - Levodopa dosing regimen (2025-05-20),

10. 12303481 - Levodopa dosing regimen (2025-05-20),

11. 12295931 - Levodopa dosing regimen (2025-05-13),

12. 12274793 - Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof (2025-04-14),

13. 12263149 - Levodopa dosing regimen (2025-04-01),

14. 12263148 - Levodopa dosing regimen (2025-04-01),

15. 12201596 - Levodopa dosing regimen (2025-01-21),

Certainly! Here is the article about inventor Suneel Gupta:

Title: Unveiling the Ingenious Mind of Suneel Gupta – Pioneering Innovations in Healthcare

Introduction:

Suneel Gupta, a visionary inventor based in Hayward, CA, has left an indelible mark in the field of pharmaceuticals with his groundbreaking patents and contributions to the medical realm. With a portfolio boasting 8 patents, Gupta has reshaped the landscape of controlled release formulations, particularly in the realm of levodopa and its derivatives.

Latest Patents:

Gupta's latest patents showcase his brilliance in pharmacological innovation. One such patent revolves around "Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa," which presents an oral solid formulation combining controlled release elements with an immediate release component to optimize drug delivery efficiency and efficacy.

Career Highlights:

Currently affiliated with Impax Laboratories, Inc., Gupta has harnessed his expertise to propel the company towards pioneering advancements in pharmaceutical technologies. His role underscores his commitment to driving innovation and pushing the boundaries of medical science.

Collaborations:

In his quest for innovation, Gupta has collaborated with esteemed colleagues such as Ann Hsu and Liang Dong, fostering a culture of creativity and teamwork. Together, they have forged synergies that have led to the development of revolutionary healthcare solutions.

Conclusion:

Suneel Gupta stands as a testament to the power of innovation and dedication in the realm of pharmaceutical inventions. His relentless pursuit of excellence and unwavering commitment to advancing healthcare technologies continue to inspire and shape the future of the industry, making him a luminary in the field of controlled release formulations.

Profile summary based on public USPTO records.